Add to Favorites Newsroom RSS Share
Houston, TX USA

Our News on Newswise

170115_McQuade_J.jpg

Obesity Associated with Longer Survival for Men with Metastatic Melanoma

Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index (BMI), investigators report in a study published in Lancet Oncology of 1,918 patients in six...
12-Feb-2018 8:05 AM EST Add to Favorites

LangFueyoGomez.jpg

Smart Bomb Virus Shows Promise as Brain Tumor Immunotherapy

A common cold virus engineered to attack the most common and deadly of brain tumors allowed 20 percent of patients with recurrent glioblastoma to live for three years or longer, researchers from The University of Texas MD Anderson Cancer Center...
12-Feb-2018 10:05 AM EST Add to Favorites

Hung_Mien_Chie2.jpg

Newly Identified Potential Therapeutic Approach Kills Triple-Negative Breast Cancer Cells in Pre-Clinical Study

Triple-negative breast cancer (TNBC), a highly aggressive, relapse-prone cancer that accounts for one-fourth of all breast cancers, could be the focus of a new area of study for immune checkpoint blockade therapy. A team of researchers at The...
9-Feb-2018 12:00 PM EST Add to Favorites

henry_kuerer.jpg

MD Anderson Study Evaluates Need for Biopsies During Follow-Up Care in Women with Early Breast Cancer

In an analysis of more than 120,000 women diagnosed with and treated for early-stage breast cancer, researchers from The University of Texas MD Anderson Cancer Center determined the rate of additional breast biopsies needed for these patients during...
30-Jan-2018 11:00 AM EST Add to Favorites

Presurgical Targeted Therapy Delays Relapse of High-Risk Stage 3 Melanoma

A pair of targeted therapies given before and after surgery for melanoma produced at least a six-fold increase in time to progression compared to standard-of-care surgery for patients with stage 3 disease, researchers at The University of Texas MD...
16-Jan-2018 10:05 AM EST Add to Favorites

JimAllison.jpeg

National Academy of Sciences Awards Kovalenko Medal to Immunotherapy Pioneer Allison

Cancer immunotherapy innovator Jim Allison, Ph.D., chair of Immunology at The University of Texas MD Anderson Cancer Center, will receive the 2018 Jessie Stevenson Kovalenko Medal for outstanding research in medical sciences, the National Academy of...
17-Jan-2018 11:05 AM EST Add to Favorites

Navin_N1.jpg

New Cancer Model Shows Genomic Link Between Early-Stage and Invasive Breast Cancer Types

A new genetic-based model may explain how a common form of early-stage breast cancer known as ductal carcinoma in situ (DCIS) progresses to a more invasive form of cancer say researchers at The University of Texas MD Anderson Cancer Center.
3-Jan-2018 12:05 PM EST Add to Favorites

218669_Chun_S.jpg

Small-Cell Lung Cancer Patients Face Barriers to Receiving Standard-of-Care Treatment

Despite decades of clinical research establishing chemotherapy with thoracic radiation as the standard-of-care for the initial management of non-metastatic small-cell lung cancer (SCLC), a large percentage of U.S. patients do not receive these...
3-Jan-2018 11:05 AM EST Add to Favorites


see all news

Our Experts on Newswise

BenjaminSmith.jpg

In a review of guideline-concordant treatment modalities for women with early stage breast cancer, mastectomy and reconstruction had the highest rate of complications and complication-related costs, regardless of age.
27-Sep-2016 3:05 PM EDT

Liang_H_Bronto.jpg

It is well known that men and women differ in terms of cancer susceptibility, survival and mortality, but exactly why this occurs at a molecular level has been poorly understood.
9-May-2016 12:00 PM EDT

ZhiminLu.jpg

Scientists know that activation of growth factor receptors like epidermal growth factor receptors (EGFR) promote tumor progression in many types of cancer.
17-Aug-2015 11:00 AM EDT

Lee_M.jpg

A protein called CSN6 has been found to be correlated with poor survival among patients with colorectal cancer, according to a study at The University of Texas MD Anderson Cancer Center.
10-Aug-2015 12:00 PM EDT

204929_Chhatwal_Jjpg.jpg

The cost of treating people infected with the hepatitis C virus (HCV) with newly approved therapies will likely place a tremendous economic burden on the country’s health care system. The prediction comes from a cost-effectiveness analysis led by...
16-Mar-2015 6:00 PM EDT

Cancer prevention experts at The University of Texas MD Anderson Cancer Center have allied with the CATCH Global Foundation, whose comprehensive child health program reaches children and their families in more than 10,000 educational settings...
18-Feb-2015 10:00 AM EST

30-Oct-2013 8:10 PM EDT

30-Oct-2013 8:00 PM EDT

see all experts

Our YouTube Videos





Chat now!